Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000188974 | SCV000242605 | likely pathogenic | not provided | 2016-12-21 | criteria provided, single submitter | clinical testing | p.Cys1588Arg (TGT>CGT): c.4762 T>C in exon 25 of the SCN1A gene (NM_001165963.1) A C1588R variant that is likely pathogenic has been identified in the SCN1A gene. The C1588R variant has been reported previously as a de novo variant in a patient with Dravet syndrome (Marini et al., 2007). The C1588R variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The C1588R variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. Additionally, this substitution alters a conserved position that is predicted to be within the transmembrane segment S2 of the fourth homologous domain, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Furthermore, missense variants in nearby residues (G1586E, V1589G) have been reported in the Human Gene Mutation Database in association with SCN1A-related disorders (Stenson et al., 2014). Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded. |
Invitae | RCV000636318 | SCV000757757 | pathogenic | Early infantile epileptic encephalopathy with suppression bursts | 2021-08-27 | criteria provided, single submitter | clinical testing | |
Uni |
RCV000059426 | SCV000090950 | not provided | Severe myoclonic epilepsy in infancy | no assertion provided | not provided |